Sovaldi : pricing of new products and consequences /
This case provides students with a specific example of a new product introduction, hepatitis C treatment, Sofosbuvir (brand name Sovaldi), introduced by Gilead to market in 2013, at a price of $1,000 per pill. The 12-week course of treatment amounted to the total cost of $84,000 and captured a lot o...
| Main Authors: | , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
London :
NeilsonJournals Publishing,
2019.
|
| Series: | SAGE Business. Cases.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Internet
Connect to the full text of this electronic bookAvailable Online
| Call Number: |
HD9665.4 .G35 2019 |
|
|---|---|---|
| Call Number | Status | Get It |
| HD9665.4 .G35 2019 | Available | |